NCT06462183 2025-11-14
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
Rgenta Therapeutics Inc
Phase 1 Recruiting
Rgenta Therapeutics Inc
Mersana Therapeutics
Novelty Nobility, Inc.